Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: A prospective study with a 1-year follow-up

International Journal of Cardiology

Volumn 102, Issue 3, 2005, Pages 447-454

  De Luca, Italo ^a   Sorino, Margherita ^a   De Luca, Leonardo ^a   Colonna, Paolo ^a   Del Salvatore, Bibiana ^a   Corlianò, Leonardo ^a  

^a POLICLINICO   (Italy)

Author keywords

Atrial fibrillation; Left atrial appendage velocities; Low molecular weight heparin; Stroke; Transesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANAMNESIS; ANTICOAGULANT THERAPY; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS RHYTHM; THROMBOEMBOLISM; TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VELOCITY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; ENOXAPARIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 21844469781     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.05.052     Document Type: Article

References (47)

1. C. Bjerkelund, and O.M. Orning The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am. J. Cardiol. 23 1969 208 216
2. D. Roy, E. Marchand, P. Gagne', M. Chabot, and R. Cartier Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation Am. Heart J. 112 1986 1039 1043
3. D.M. Weinberg, and G.B.J. Mancini Anticoagulation for cardioversion of atrial fibrillation Am. J. Cardiol. 63 1989 745 746
4. A.Z. Arnold, M.J. Mick, R.P. Mazurek, F.D. Loop, and R.G. Trohman Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter J. Am. Coll. Cardiol. 19 1992 851 855
5. J.J. Morris, R.H. Peter, H.D. McIntosh, Y. Kong, and W.C. North Experience with cardioversion of atrial fibrillation and flutter Am. J. Cardiol. 14 1964 94 100
6. A. Laupacis, G. Albers, and M. Dunn Antithrombotic therapy in atrial fibrillation Chest 102 Suppl 1992 426S 433S
7. G.W. Albers, C.J. Dalen, A. Laupacis, W.J. Manning, P. Petersen, and D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 119 2001 194S 206S
8. A.C. Pearson, A.J. Labovitz, S. Tatineni, and C.R. Gomez Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology J. Am. Coll. Cardiol. 17 1991 66 72
9. R.A. Grimm, W.J. Stewart, I.W. Black, J.D. Thomas, and A.L. Klein Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation? J. Am. Coll. Cardiol. 23 1994 533 541
10. D.I. Silverman, and W.J. Manning Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation Circulation 98 1998 479 486
11. W.J. Manning, R.M. Weintraub, C.A. Waksmonski, J.M. Haering, P.S. Rooney, and A.D. Maslow Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study Ann. Intern. Med. 123 1995 817 822
12. A.L. Klein, R.A. Grimm, I.W. Black, D.Y. Leung, M.K. Chung, and S.E. Vaughn Cardioversion guided by transesophageal echocardiography: the ACUTE pilot study: a randomized, controlled trial Ann. Intern. Med. 126 1997 200 209
13. I.W. Black, D. Fatkin, K.B. Sagar, B.K. Khanderia, D.Y. Leung, and J.M. Galloway Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study Circulation 89 1994 2509 2513
14. R.A. Grimm, D.Y. Leung, I.W. Black, W.J. Stewart, J.D. Thomas, and A.L. Klein Left atrial appendage «stunning» after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography Am. Heart J. 130 1995 174 176
15. R.A. Grimm, W.J. Stewart, J.D. Malooney, G.I. Cohen, G.L. Pearce, and E.E. Salcedo Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast characterization by simultaneous transesophageal echocardiography J. Am. Coll. Cardiol. 22 1993 1359 1366
16. I. de Luca, M. Sorino, B. Del Salvatore, and L. De Luca A new therapeutic strategy for electrical cardioversion of atrial fibrillation Ital. Heart J. 2 2001 831 840
17. W.N. Irani, P.A. Grayburn, and I. Afridi Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: a prospective study using transoesophageal echocardiography Circulation 95 1997 962 966
18. D. Fatkin, R.P. Kelly, and M.P. Feneley Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thrombo-embolic risk in vivo J. Am. Coll. Cardiol. 23 1994 961 969
19. D. Fatkin, D.L. Kuchar, C.W. Thorburn, and M.P. Feneley Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for «atrial stunning» as a mechanism of thrombo-embolic complications J. Am. Coll. Cardiol. 23 1994 307 316
20. Y. Agmon, B.K. Khandheria, F. Gentile, and J.B. Seward Echocardiographic assessment of the left atrial appendage J. Am. Coll. Cardiol. 34 1999 1867 1877
21. B. Lown, R. Amarasingham, and J. Neuman New method for terminating cardiac arrhythmias JAMA 182 1962 548 555
22. M. Berger, and P. Schweitzer Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis Am. J. Cardiol. 82 1998 1545 1546
23. A.L. Klein, R.A. Grimm, R.D. Murray For the Assessment of Cardioversion Using Transesophageal Echocardiography Investigators Use of transesophageal ecocardiography to guide cardioversion in patients with atrial fibrillation N. Engl. J. Med. 344 2001 1411 1420
24. W.J. Manning, D.I. Silverman, C.S. Keighley, P. Oettgen, and P.S. Douglas Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short term anticoagulation: final results of a prospective 4.5-year study J. Am. Coll. Cardiol. 25 1995 1354 1361
25. V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA guide-lines for management of patients with atrial fibrillation J. Am. Coll. Cardiol. 38 2001 1266 1336
26. J. Schlicht, R. Davis, K. Naqi, W. Cooper, and V. Rao Physician practices regarding anticoagulation and cardioversion of atrial fibrillation Arch. Intern. Med. 156 1996 290 294
27. U. Tebbe, J. Carlson, and K. Seidl Cardioversion in atrial fibrillation. Results and complications in 1152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians Med. Klin. 90 1995 681 687
28. M.N. Levine, G. Raskob, S. Landefeld, and J. Hirsh Hemorrhagic complications of anticoagulant treatment Chest 108 1995 276S 290S
29. J.I. Weitz Drug therapy: low-molecular-weight heparins N. Engl. J. Med. 337 1997 688 699
30. W. Klei, A. Buchwald, and S.E. Hillis Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease Circulation 96 1997 61 68
31. M. Levine, M. Gent, and J. Hirsh A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis N. Engl. J. Med. 334 1996 677
32. I. de Luca, M. Sorino, P. Colonna, L. De Luca, and B. Del Salvatore Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients Circulation 106 Suppl II 2002 706
33. A. Roijer, J. Eskilsson, and B. Olssen Transesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter: selection of a low-risk group for immediate cardioversion Eur. Heart J. 21 2000 837 847
34. R.D. Murray, A. Shah, and S. Jasper Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study Am. Heart J. 139 2000 e5
35. A.M. Wodlinger, and J.A. Pieper Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation Pharmacotherapy 23 2003 57 63
36. T. Ito, M. Suwa, Y. Otake, A. Kobashi, Y. Hirota, and H. Ando Assessment of left atrial appendage function after cardioversion of atrial fibrillation: relation to left atrial mechanical function Am. Heart J. 135 1998 1020 1026
37. H. Omran, W. Jung, R. Rabahieh, R. Schimpf, C. Wolpert, and A. Hagendorff Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study J. Am. Coll. Cardiol. 29 1997 131 138
38. K. Harjai, S. Mobarek, F. Abi-Samra, Y. Gilliland, N. Davison, and K. Drake Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion Am. J. Cardiol. 81 1998 1125 1129
39. E. Antonielli, A. Pizzuti, and A. Palinkas Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation J. Am. Coll. Cardiol. 39 2002 1443 1449
40. O. Kamp, P.M.J. Verhorst, R.C. Welling, and C.A. Visser Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation Eur. Heart J. 20 1999 979 985
41. M. Sorino, B. Del Salvatore, P. Colonna, E. Fino, and I. de Luca Transoesophageal echocardiography for prolonged left atrial appendage dysfunction after electric DC shock for atrial fibrillation Eur. Heart J. (Abstr.) 23 2002 177
42. I.C. Van Gelder, V.E. Hegens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N. Engl. J. Med. 347 2002 1834 1840
43. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N. Engl. J. Med. 347 2002 1825 1833
44. R.H. Falk Management of atrial fibrillation-radical reform or modest modification? N. Engl. J. Med. 347 2002 1883 1884
45. M. Pozzoli, A. Selva, and D. Skouse Visualization of left atrial appendage and assessment of its function by transthoracic second harmonic imaging and contrast-enhanced pulsed Doppler Eur. J. Echocardiog. 3 1 2002 (Mar) 13 23
46. M. Sorino, P. Colonna, B. Del Salvatore, L. De Luca, L. Corlianò, and I. de Luca New monodimensional transthoracic 2nd harmonic echocardiography sign of left atrial appendage function Circulation 108 Suppl 2003 N2213 (abstr)
47. R.D. Murray, S.R. Deitcher, and A. Shah Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (Enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation J. Am. Soc. Echocardiogr. 14 2001 200 208